- Home
- BUSE vs TARS Comparison
BUSE vs TARS Comparison
Compare BUSE & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- TARS
- Stock Information
- Founded
- BUSE 1868
- TARS 2016
- Country
- BUSE United States
- TARS United States
- Employees
- BUSE N/A
- TARS N/A
- Industry
- BUSE Major Banks
- TARS Medicinal Chemicals and Botanical Products
- Sector
- BUSE Finance
- TARS Health Care
- Exchange
- BUSE Nasdaq
- TARS Nasdaq
- Market Cap
- BUSE 2.0B
- TARS 1.7B
- IPO Year
- BUSE N/A
- TARS 2020
- Fundamental
- Price
- BUSE $24.44
- TARS $49.59
- Analyst Decision
- BUSE Buy
- TARS Strong Buy
- Analyst Count
- BUSE 7
- TARS 7
- Target Price
- BUSE $27.43
- TARS $67.14
- AVG Volume (30 Days)
- BUSE 449.7K
- TARS 665.6K
- Earning Date
- BUSE 10-21-2025
- TARS 11-12-2025
- Dividend Yield
- BUSE 4.09%
- TARS N/A
- EPS Growth
- BUSE N/A
- TARS N/A
- EPS
- BUSE 1.13
- TARS N/A
- Revenue
- BUSE $498,525,000.00
- TARS $295,521,000.00
- Revenue This Year
- BUSE $62.58
- TARS $33,170.29
- Revenue Next Year
- BUSE $11.62
- TARS N/A
- P/E Ratio
- BUSE $21.71
- TARS N/A
- Revenue Growth
- BUSE 16.77
- TARS 254.45
- 52 Week Low
- BUSE $18.40
- TARS $30.23
- 52 Week High
- BUSE $28.30
- TARS $59.76
- Technical
- Relative Strength Index (RSI)
- BUSE 56.45
- TARS 37.83
- Support Level
- BUSE $24.50
- TARS $55.45
- Resistance Level
- BUSE $25.18
- TARS $59.76
- Average True Range (ATR)
- BUSE 0.44
- TARS 2.04
- MACD
- BUSE -0.03
- TARS -1.47
- Stochastic Oscillator
- BUSE 46.76
- TARS 12.02
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.